Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

An Alternative Approach for Improved Entrapment Efficiency of Hydrophilic Drug Substance in PLGA Nanoparticles by Interfacial Polymer Deposition Following Solvent Displacement

Sara Salatin 1 , 2 , Jaleh Barar 1 , 3 , Mohammad Barzegar-Jalali 3 , Khosro Adibkia 3 , 4 , Farhad Kiafar 3 , 5 and Mitra Jelvehgari 3 , 4 , *
Authors Information
1 Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
2 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
4 Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
5 Zahravi Pharmaceutical Company, Tabriz, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: 13 (4); e12873
  • Published Online: December 2, 2018
  • Article Type: Research Article
  • Received: August 26, 2016
  • Revised: December 12, 2017
  • Accepted: January 7, 2018
  • DOI: 10.5812/jjnpp.12873

To Cite: Salatin S, Barar J, Barzegar-Jalali M , Adibkia K, Kiafar F, et al. An Alternative Approach for Improved Entrapment Efficiency of Hydrophilic Drug Substance in PLGA Nanoparticles by Interfacial Polymer Deposition Following Solvent Displacement, Jundishapur J Nat Pharm Prod. Online ahead of Print ; 13(4):e12873. doi: 10.5812/jjnpp.12873.

Copyright © 2018, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Di Stefano A, Iannitelli A, Laserra S, Sozio P. Drug delivery strategies for Alzheimer's disease treatment. Expert Opin Drug Deliv. 2011;8(5):581-603. doi: 10.1517/17425247.2011.561311. [PubMed: 21391862].
  • 2. Jain KK. Nanobiotechnology-based strategies for crossing the blood-brain barrier. Nanomedicine (Lond). 2012;7(8):1225-33. doi: 10.2217/nnm.12.86. [PubMed: 22931448].
  • 3. Salatin S, Maleki Dizaj S, Yari Khosroushahi A. Effect of the surface modification, size, and shape on cellular uptake of nanoparticles. Cell Biol Int. 2015;39(8):881-90. doi: 10.1002/cbin.10459. [PubMed: 25790433].
  • 4. Dizaj SM, Vazifehasl Z, Salatin S, Adibkia K, Javadzadeh Y. Nanosizing of drugs: Effect on dissolution rate. Res Pharm Sci. 2015;10(2):95-108. [PubMed: 26487886]. [PubMed Central: PMC4584458].
  • 5. Salatin S, Jelvehgari M, Maleki-Dizaj S, Adibkia K. A sight on protein-based nanoparticles as drug/gene delivery systems. Ther Deliv. 2015;6(8):1017-29. doi: 10.4155/tde.15.28. [PubMed: 26305428].
  • 6. Tosi G, Bortot B, Ruozi B, Dolcetta D, Vandelli MA, Forni F, et al. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. Curr Med Chem. 2013;20(17):2212-25. doi: 10.2174/0929867311320170006. [PubMed: 23458620].
  • 7. Fessi HPFD, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 1989;55(1):R1-4. doi: 10.1016/0378-5173(89)90281-0.
  • 8. Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm. 1998;24(12):1113-28. doi: 10.3109/03639049809108571. [PubMed: 9876569].
  • 9. Sharma D, Maheshwari D, Philip G, Rana R, Bhatia S, Singh M, et al. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: In vitro and in vivo evaluation. Biomed Res Int. 2014;2014:156010. doi: 10.1155/2014/156010. [PubMed: 25126544]. [PubMed Central: PMC4122152].
  • 10. Loveymi BD, Jelvehgari M, Zakeri-Milani P, Valizadeh H. Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability. Adv Pharm Bull. 2012;2(1):43-56. doi: 10.5681/apb.2012.007. [PubMed: 24312770]. [PubMed Central: PMC3846008].
  • 11. Benkic P, Smrkolj M, Pecavar A, Stropnik T, Vrbinc M, Vrecer F, et al. Amorphous and crystalline forms of rivastigmine hydrogen tartrate. Eur Pat Applic. 2008:1-30.
  • 12. Liu J, Qiu Z, Wang S, Zhou L, Zhang S. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity. Biomed Mater. 2010;5(6):65002. doi: 10.1088/1748-6041/5/6/065002. [PubMed: 20924138].
  • 13. Derman S. Caffeic acid phenethyl ester loaded PLGA nanoparticles: effect of various process parameters on reaction yield, encapsulation efficiency, and particle size. J Nanomaterials. 2015;16(1):318. doi: 10.1080/10915810802244595.
  • 14. Domanska U, Halayqa M. Promazine Hydrochloride/PLGA biodegradable nanoparticles formulation and release. J Phys Chem Biophys. 2014;4(2):1000143. doi: 10.4172/2161-0398.1000143.
  • 15. Tefas LR, Tomuta I, Achim M, Vlase L. Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. Clujul Med. 2015;88(2):214-23. doi: 10.15386/cjmed-418. [PubMed: 26528074]. [PubMed Central: PMC4576773].
  • 16. Salatin S, Barar J, Barzegar-Jalali M, Adibkia K, Kiafar F, Jelvehgari M. Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles. Res Pharm Sci. 2017;12(1):1. doi: 10.4103/1735-5362.199041. [PubMed: 28255308]. [PubMed Central: PMC5333474].
  • 17. Amaro MI, Simon A, Cabral LM, de Sousa VP, Healy AM. Rivastigmine hydrogen tartrate polymorphs: Solid-state characterisation of transition and polymorphic conversion via milling. Solid State Sci. 2015;49:29-36. doi: 10.1016/j.solidstatesciences.2015.09.004.
  • 18. Graeser KA, Strachan CJ, Patterson JE, Gordon KC, Rades T. Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin. Crystal Growth Design. 2008;8(1):128-35. doi: 10.1021/cg700913m.
  • 19. Joshi SA, Chavhan SS, Sawant KK. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur J Pharm Biopharm. 2010;76(2):189-99. doi: 10.1016/j.ejpb.2010.07.007. [PubMed: 20637869].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments